The BRCA1 exon 13 duplication: clinical characteristics of 22 families in Northern Sweden

The clinical management of BRCA1/2 mutation carriers requires accurate cancer risk estimates. Cancer risks vary according to type and location of the mutation and since there is limited information about mutation-specific cancer risks, genotype-phenotype correlation studies are needed. This is a rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwinsdotter Ardnor, Christina, Rosén, Anna, Ljuslinder, Ingrid, Melin, Beatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2018
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323134/
https://www.ncbi.nlm.nih.gov/pubmed/30136106
http://dx.doi.org/10.1007/s10689-018-0098-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323134/
https://www.ncbi.nlm.nih.gov/pubmed/30136106
http://dx.doi.org/10.1007/s10689-018-0098-y

Ejemplares similares